The results showed that both doses of salvianolic acid A (17) improved the symptoms of colitis, regulated the intestinal microbiota, and reduced the expression of inflammatory factors IL-1β, monocyte chemotactic protein-1 (MCP-1), and IL-6 in a dose-dependent manner. This evidence concerns the gene CCL2 and colitis.